Chemed Corp. (NYSE: CHE) reported Q2 EPS of $1.50, $0.03 better than the analyst estimate of $1.47. Revenue for the quarter came in at $360 million versus the consensus estimate of $363.73 million.

For earnings history and earnings-related data on Chemed Corp. (CHE) click here.